Position in VIR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$861,459
+$369,345 QoQ
Shares Held
96,145
+17.8% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $14,301,022,166 across 256 Biotechnology names. VIR ranks #161 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
3,374,955 | $2,464,560,888 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,177,527 | $1,682,444,460 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,760,122 | $785,964,877 | |
| 4 | INSM |
INSMED Inc
|
3,092,807 | $505,735,799 | |
| 5 | KYMR |
Kymera Therapeutics, Inc.
|
6,060,847 | $504,807,946 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,432,748 | $474,053,330 | |
| 7 | ASND |
Ascendis Pharma A/S
|
1,530,345 | $350,035,811 | |
| 8 | RVMD |
Revolution Medicines, Inc.
|
3,232,213 | $314,332,713 |
All Filings in VIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $861,459 | 96,145 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $492,114 | 81,611 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $269,146 | 47,136 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $216,392 | 42,935 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $483,913 | 74,678 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $523,576 | 71,332 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $508,016 | 67,826 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $514,802 | 57,843 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $540,729 | 53,379 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $871,236 | 86,604 | Shares | Sole | 2024-02-16 | |
| 2023-09-30 | $2,210,635 | 235,927 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $19,673,893 | 802,034 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,004,209 | 386,945 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,760,750 | 385,648 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,434,540 | 385,609 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,496,448 | 176,539 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $11,583,336 | 450,363 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $25,014,519 | 597,433 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,589,306 | 36,519 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,586,329 | 75,853 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $3,177,663 | 61,979 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,751,840 | 65,416 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $908,234 | 26,456 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||